Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findingsStefan Kubicka, Christophe Borg, Richard Greil et al.|Annals of Oncology|2013Cited by 104
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study GroupLisa Pleyer, Richard Greil, Reinhard Stauder et al.|International Journal of Molecular Sciences|2017Cited by 51
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOXJean‐François Emile, Yves Humblet, Catherine Julié et al.|European Journal of Cancer|2017Cited by 47
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial datasetJosef Thaler, Mohamed-Ayman Zawadi, Richard Greil et al.|Annals of Oncology|2015Cited by 4